Literature DB >> 3701338

Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671.

R J Lukas.   

Abstract

Studies were conducted on curaremimetic neurotoxin binding to the nicotinic acetylcholine receptor present on membrane fractions derived from the human medulloblastoma clonal line, TE671. High-affinity binding sites (KD = 2 nM for 1-h incubation at 20 degrees C) and low-affinity binding sites (KD = 40 nM) for 125I-labeled alpha-bungarotoxin are present in equal quantities (60 fmol/mg membrane protein). The kinetically determined dissociation constant for high-affinity binding of toxin is 0.56 nM (k1 = 6.3 X 10(-3) min-1 nM-1; k-1 = 3.5 X 10(-3) min-1) at 20 degrees C. Nicotine, d-tubocurarine, and acetylcholine are among the most effective inhibitors of high-affinity toxin binding. The quantity of toxin binding sites and their affinity for cholinergic agonists is sensitive to reduction, alkylation, and/or oxidation of membrane sulfhydryl residues. High-affinity toxin binding sites that have been subjected to reaction with the sulfhydryl reagent dithiothreitol are irreversibly blocked by the nicotinic receptor affinity reagent bromoacetylcholine. High-affinity toxin binding is inhibited in the presence of either of two polyclonal antisera or a monoclonal antibody raised against nicotinic acetylcholine receptors from fish electric tissue. Taken together, these results indicate that curaremimetic neurotoxin binding sites on membrane fractions of the TE671 cell line share some properties with nicotinic acetylcholine receptors of peripheral origin and with toxin binding sites on other neuronal tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701338     DOI: 10.1111/j.1471-4159.1986.tb08516.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.

Authors:  Richard W Fitch; Thomas F Spande; H Martin Garraffo; Herman J C Yeh; John W Daly
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

2.  The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors.

Authors:  P G Purohit; R J Tate; E Pow; D Hill; J G Connolly
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

3.  Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.

Authors:  R J Lukas; C M Eisenhour
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

4.  Immunochemical and pharmacological distinctions between curaremimetic neurotoxin binding sites of central, autonomic, and peripheral origin.

Authors:  R J Lukas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Cholinergic stimulation of the Na+/K+ adenosine triphosphatase as revealed by microphysiometry.

Authors:  D L Miller; J C Olson; J W Parce; J C Owicki
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

6.  Discovery of novel alpha7 nicotinic receptor antagonists.

Authors:  Youyi Peng; Qiang Zhang; Gretchen L Snyder; Hongwen Zhu; Wei Yao; John Tomesch; Roger L Papke; James P O'Callaghan; William J Welsh; Lawrence P Wennogle
Journal:  Bioorg Med Chem Lett       Date:  2010-06-25       Impact factor: 2.823

7.  Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function.

Authors:  Richard W Fitch; Yingxian Xiao; Kenneth J Kellar; John W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-25       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.